Dopamine Effect on Inhibitory Control

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

September 30, 2020

Primary Completion Date

January 20, 2023

Study Completion Date

November 10, 2023

Conditions
Idiopathic Parkinson's Disease
Interventions
DRUG

PD patients H&Y=1.5-2 Medications ON

Parkinson's patients will be allowed to the first-morning dose of levodopa medicament (levodopa, dopamine agonists, anticholinergic drugs, or a combination of levodopa and an anticholinergic drug) which normally allowed the patient to attain the best control of symptoms one hour before being tested (19). Patients will perform both the stop-signal task and the go-only task. Experimental conditions will be counterbalanced across patients.

DRUG

PD patients H&Y=1.5-2 Medications OFF

Parkinson's patients will not take medications overnight prior to the study (20). Patients will perform both the stop-signal task and the go-only task. Experimental conditions will be counterbalanced across patients. This intervention will be given on a different day with respect to the Medication ON intervention. The order of intervention will be counterbalanced across subjects

BEHAVIORAL

Healthy age-matched controls

Healthy controls will perform the stop signal task and the go-only task in the same day. The order of administration will be counterbalanced.

DRUG

PD patients H&Y=3 Medications OFF

Parkinson's patients will not take medications overnight prior to the study (20). Patients will perform both the stop-signal task and the go-only task. Experimental conditions will be counterbalanced across patients. This intervention will be given on a different day with respect to the Medication ON intervention. The order of intervention will be counterbalanced across subjects

DRUG

PD patients H&Y=3 Medications ON

Parkinson's patients will be allowed to the first-morning dose of levodopa medicament (levodopa, dopamine agonists, anticholinergic drugs, or a combination of levodopa and an anticholinergic drug) which normally allowed the patient to attain the best control of symptoms one hour before being tested (19). Patients will perform both the stop-signal task and the go-only task. Experimental conditions will be counterbalanced across patients.

Trial Locations (1)

86077

IRCSS Neuromed Hospital, Pozzilli

All Listed Sponsors
lead

Giovanni Mirabella

OTHER

NCT03665493 - Dopamine Effect on Inhibitory Control | Biotech Hunter | Biotech Hunter